Daobin Zhou
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Neurology top 1%
- Peripheral Neuropathies and Disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 69
- Oncology 78
- Viral-associated cancers and disorders 34
- Co-authors
- Li J (114 shared papers)Xinxin Cao (130 shared papers)Minghui Duan (77 shared papers)Lu Zhang (38 shared papers)Wei Zhang (56 shared papers)Hao Cai (36 shared papers)Yan Zhang (59 shared papers)Jian Sun (20 shared papers)
- Journals
- Blood (34 papers)Annals of Hematology (30 papers)Leukemia Research (11 papers)Orphanet Journal of Rare Diseases (9 papers)Frontiers in Oncology (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Daobin Zhou
280 papers receiving 3.5k citations
Daobin Zhou's Hit Papers
Peers
Comparison fields: 5 of 112
- Hematology 884
- Neurology 902
- Genetics 626
- Pathology and Forensic Medicine 964
- Oncology 904
Countries citing papers authored by Daobin Zhou
This map shows the geographic impact of Daobin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daobin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daobin Zhou more than expected).
Fields of papers citing papers by Daobin Zhou
This network shows the impact of papers produced by Daobin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daobin Zhou. The network helps show where Daobin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Daobin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 311 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 272 | |
| 2 | 2018 | 210 | |
| 3 | The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update Hit paper breakdown → | 2021 | 164 |
| 4 | 2011 | 110 | |
| 5 | 2011 | 97 | |
| 6 | 2020 | 97 | |
| 7 | 2016 | 79 | |
| 8 | 2020 | 76 | |
| 9 | 2013 | 58 | |
| 10 | 2018 | 51 | |
| 11 | 2012 | 51 | |
| 12 | 2019 | 48 | |
| 13 | 2021 | 42 | |
| 14 | 1999 | 40 | |
| 15 | 2010 | 39 | |
| 16 | 2023 | 38 | |
| 17 | 2019 | 37 | |
| 18 | 2021 | 35 | |
| 19 | 2021 | 34 | |
| 20 | 2014 | 32 |
About Daobin Zhou
Daobin Zhou is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Neurology and Hematology, having authored 311 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (69 papers), Chronic Lymphocytic Leukemia Research (39 papers), Viral-associated cancers and disorders (34 papers), CNS Lymphoma Diagnosis and Treatment (33 papers), Peripheral Neuropathies and Disorders (33 papers), Histiocytic Disorders and Treatments (31 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers) and Multiple Myeloma Research and Treatments (22 papers). The work is most often cited by research in Hematology (884 citations), Neurology (902 citations), Genetics (626 citations), Pathology and Forensic Medicine (964 citations) and Oncology (904 citations). Daobin Zhou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Li J, Xinxin Cao, Minghui Duan, Lu Zhang, Wei Zhang, Hao Cai, Yan Zhang, Jian Sun, Ting Liu and Jun Feng. Their work appears in journals such as Blood, Annals of Hematology, Leukemia Research, Orphanet Journal of Rare Diseases and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.